Niagen Bioscience, Inc. Share Price & Technical Analysis
NAGE · $3.66 (-3.43%)
Healthcare / Biotechnology
$3.66
-3.43%
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulate…
Price chart
Seasonality
May has 2 positive and 2 negative years (last 5 years shown)
-21% return in May, 9% avg return in past 3 year May month.
-46% return in 2026, 75% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -6% | -14% | -12% | 7% | -21% | – | – | – | – | – | – | – | -46% |
| 25 | 4% | 2% | 21% | 15% | 38% | 32% | -35% | 8% | -3% | -18% | -12% | -4% | 48% |
| 24 | 7% | 13% | 106% | 0% | -20% | -4% | 7% | 17% | 6% | -5% | 88% | -32% | 183% |
| 23 | 18% | -15% | -12% | -13% | 8% | 7% | 13% | -6% | -6% | -7% | 8% | 0% | -6% |
| 22 | -26% | -4% | -7% | -24% | 0% | -11% | 0% | -22% | -14% | 15% | 13% | 0% | -80% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and authorized healthcare practitioners resellers. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$303.44M
P/E ratio
18.14
52W high
$14.69
52W low
$3.57
Volume
7,30,580
Beta
2.17
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Niagen Bioscience, Inc. share price today?
- Niagen Bioscience, Inc. (NAGE) last traded around $3.66 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does NAGE have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for NAGE. Download the app for real-time alerts.
- How can I analyze Niagen Bioscience, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.